Cargando…
Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
Osteosarcoma is the most common primary malignant bone tumour in children and adolescents. More than a third of patients do not respond to standard therapy and urgently require alternative treatment options. Due to a high degree of inter‐ and intra‐tumoural genomic heterogeneity and complexity, recu...
Autores principales: | Ameline, Baptiste, Kovac, Michal, Nathrath, Michaela, Barenboim, Maxim, Witt, Olaf, Krieg, Andreas H, Baumhoer, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869926/ https://www.ncbi.nlm.nih.gov/pubmed/33295144 http://dx.doi.org/10.1002/cjp2.191 |
Ejemplares similares
-
The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies
por: Kovac, Michal, et al.
Publicado: (2021) -
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
por: Barenboim, Maxim, et al.
Publicado: (2021) -
NTRK fusions in osteosarcoma are rare and non‐functional events
por: Ameline, Baptiste, et al.
Publicado: (2020) -
Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics
por: Engert, Florian, et al.
Publicado: (2016) -
Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?
por: Ameline, Baptiste, et al.
Publicado: (2022)